A detailed history of Mather Group, Llc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Mather Group, Llc. holds 6,621 shares of BSX stock, worth $598,935. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,621
Previous 7,654 13.5%
Holding current value
$598,935
Previous $589,000 5.94%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$72.96 - $84.0 $75,367 - $86,772
-1,033 Reduced 13.5%
6,621 $554,000
Q2 2024

Jul 08, 2024

BUY
$67.33 - $77.71 $86,384 - $99,701
1,283 Added 20.14%
7,654 $589,000
Q1 2024

Apr 08, 2024

SELL
$57.6 - $68.62 $41,587 - $49,543
-722 Reduced 10.18%
6,371 $436,000
Q4 2023

Feb 05, 2024

BUY
$48.64 - $57.81 $3,502 - $4,162
72 Added 1.03%
7,093 $410,000
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $19,373 - $21,106
386 Added 5.82%
7,021 $370,000
Q2 2023

Aug 08, 2023

BUY
$49.72 - $54.64 $329,892 - $362,536
6,635 New
6,635 $358,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.